|List [record 1 of 1]|
|Coordinate||103,820,013 bp (GRCm38)|
|Base Change||C ⇒ T (forward strand)|
|Gene Name||endothelin receptor type B|
|Synonym(s)||ETb, ETR-b, Sox10m1|
|Chromosomal Location||103,814,625-103,844,402 bp (-)|
FUNCTION: This gene encodes a member of the G-protein coupled receptor family. It encodes a receptor for endothelins, peptides that are involved in vasocontriction. The encoded protein activates a phosphatidylinositol-calcium second messenger system and is required for the development of enteric neurons and melanocytes. Gene disruption causes pigmentation anomalies, deafness, and abnormal dilation of the colon due to defects of neural crest-derived cells. Mutations in this gene are found in the piebald mouse, and mouse models of Hirschsprung's disease and Waardenburg syndrome type 4. Renal collecting duct-specific gene deletion causes sodium retention and hypertension. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2013]
PHENOTYPE: Mice homozygous for null mutations have pigmentation limited to small patches on the head and rump and die from megacolon resulting from impaired neural crest migration and aganglionosis. Heterozygotes for a null allele show improved cardiac tolerance to hypoxia. [provided by MGI curators]
|Amino Acid Change||Glycine changed to Aspartic acid|
|Institutional Source||Beutler Lab|
|Gene Model||predicted gene model for protein(s): [ENSMUSP00000022718] [ENSMUSP00000126057] [ENSMUSP00000154806]|
AA Change: G371D
|Predicted Effect||probably damaging
PolyPhen 2 Score 0.999 (Sensitivity: 0.14; Specificity: 0.99)
AA Change: G371D
|Predicted Effect||probably damaging
PolyPhen 2 Score 0.999 (Sensitivity: 0.14; Specificity: 0.99)
|Predicted Effect||probably damaging
PolyPhen 2 Score 0.999 (Sensitivity: 0.14; Specificity: 0.99)
|Alleles Listed at MGI|
|Mode of Inheritance||Autosomal Recessive|
|Local Stock||Live Mice, Sperm|
|Last Updated||2018-05-29 2:55 PM by Anne Murray|
|Record Created||2013-06-21 9:50 PM by Tiana Purrington|
The hypopigmentation phenotype of gus-gus mice was initially identified among N-ethyl-N-nitrosourea (ENU)-induced G3 animals; the gus-gus homozygous mice have a piebald appearance (i.e., a variable black and white spotting pattern; Figure 1). Although they appear healthy at birth, the gus-gus mice die prematurely at or around weaning; cause of death has not been determined.
|Nature of Mutation|
Whole exome HiSeq sequencing of the G1 grandsire identified 61 mutations, one of which affected Ednrb, a gene known to cause pied spotting when mutated (1). The Ednrb mutation is a G to A transition at base pair 103,820,013 (v38) on Chromosome 14, or base pair 24,161 in the GenBank genomic region NC_000080 encoding Ednrb. The mutation corresponds to residue 1,337 in the mRNA sequence NM_007904.4 within exon 6 of 7 total exons or residue 1,523 in the mRNA sequence NM_001136061.2 within exon 7 of 8 total exons.
Genomic sequence is shown; numbering corresponds to NC_000080. The mutated nucleotide is indicated in red. The mutation results in a glycine (G) to aspartic acid (D) substitution at amino acid 371 in both endothelin receptor type B (ETBR) isoforms.
Ednrb encodes endothelin receptor type B (ETBR), a member of the endothelin (ET) receptor family of rhodopsin-like G protein-coupled receptors (GPCRs; see the record for Bemr3) (2-5). The rhodopsin-like GPCRs have seven helical transmembrane domains, three extracellular and three intracellular loops, an extracellular N-terminus, and a cytoplasmic C-terminus (Figure 2).
The extracellular N-terminus of ETBR has several known functions (3). Within the endoplasmic reticulum (ER) lumen, a signal peptide comprised of the N-terminal 26 amino acids is cleaved after facilitating the translocation of ETBR across the ER membrane (6;7). At the cell surface, the N-terminus of the mature protein is further susceptible to ligand (ET-1)-induced cleavage between Arg65 and Ser66 by an unidentified extracellular soluble or membrane-bound metalloprotease (e.g., a member of a disintegrin and metalloprotease (ADAM) family (see the record for wavedx for information about Adam17) or matrix metalloprotease (MMP; see the record for cartoon for information about Mmp14)) (8-10). A mutant ETBR lacking the first 64 amino acids retained the functional properties of full-length ETBR when expressed in vitro, however, there was a 15-fold reduction in cell-surface expression (8). These data indicate that N-terminal proteolysis of ETBR regulates ETBR cell surface expression (8). A region containing 29 amino acids of the N-terminus adjacent to the first transmembrane domain (amino acids 74-101 in mouse) functions to stabilize the interaction between the endothelin ligand(s) and ETBR (11). Takasuka et al. propose that the 29 N-terminal amino acids may interact with another part of ETBR (e.g., the extracellular loops) to stabilize the receptor-ligand complex (11). For example, the binding of the ET ligand, ET-1, to ETBR is almost irreversible (11;12); when exposed to acid washes and 2% SDS, the receptor-ligand complex remains intact (13). The complex within living cells remains stable even when transported into late endosomal/lysosomal compartments (14).
The transmembrane domains (TM) and the intervening extracellular loops of ETBR regulate agonist selectivity and binding (15;16). The ligand binding domain of ETBR is Ile138-Ile197 within the second transmembrane domain (17).
The C-terminal tail of ETBR is essential for Gαq protein coupling and the regulation of the stimulation of the epithelial sodium/hydrogen exchanger 3 (NHE3), a protein necessary for renal and intestinal sodium reabsorption (18;19). The amino acid sequence 399Ser-Cys-Leu-Cys402 within the C-terminal tail is conserved between ETBR and ETAR, another member of the ET receptor family, and is proposed to be essential for signal transduction (18). The C-terminal tail of ETBR also directs the receptor’s intracellular trafficking route irrespective of ligand stimulation (20). ETBR is initially transported to the plasma membrane and then internalized to lysosomes where it undergoes proteolytic degradation (20). The C-terminal tail of ETBR mediates the interaction with β-arrestin and subsequent internalization of the receptor, lysosomal sorting, and its degradation (20;21).
ETBR undergoes several posttranslational modifications: (i) Asn60 is within an N-linked glycosylation consensus sequence (Asn-X-Ser/Thr), however, this site is released upon the proteolytic processing of ETBR; no other glycosylation occurs on ETBR (3;6;22). (ii) Thirteen potential phosphorylation sites (most at the end of the C-terminus; aa 435-442) have been identified (15;23). ETBR phosphorylation is proposed to regulate receptor function as well as receptor desensitization by GPCR kinase or β-arrestin-mediated phosphorylation (15;23). (iii) Three cysteines (Cys402, 403, and 405) within the C-terminal tail are potential palmitoylation sites (24). (iv) Cysteines 174 and 225 are proposed to cross-link extracellular loops one and two by a disulfide bond (25).
ETBR couples to the Gαi subunit of the heterotrimeric G-protein at the third intracellular loop (amino acids 297-324) (26;27). A consensus sequence including Lys210, Val214, Pro215, Lys216, and Val220 (210LysXXXValProLysXXXVal220) within the second intracellular loop of ETBR is required for ET-1-mediated stimulation of NHE3 (19).
ETBR may form homodimers as well as heterodimers or higher order oligomers with ETAR (15). Formation of the dimers or higher order oligomers is proposed to function in modifying ligand binding, receptor activation, densensitization and transmembrane signaling (15).
In humans, an alternative ETBR isoform (ETB-SVR) is generated by the use of an alternative splice site within exon 7 (base pair 2,970) in human EDNRB (18). ETB-SVR differs from the canonical ETBR sequence at the intracellular C-terminal domain and the 3’-untranslated region (18). In contrast to the canonical ETBR C-terminal tail (amino acids 398-442) that has five cysteines, nine serines, two tyrosines, and no threonine, the ETB-SVR C-terminal tail (amino acids 398-436) has one cysteine, two serines, two threonines, and no tyrosines (18). ETB-SVR is functionally distinct from ETBR; a possible function of ETB-SVR has not been identified (18). The extent of C-terminal tail phosphorylation by β-adrenergic receptor kinase-like may explain, in part, the functional difference between ETBR and ETB-SVR (18). Another study identified a third, ETBR isoform (ETB1) in human brain, placenta, lung, and heart by reverse transcriptase polymerase chain reaction; ETB1 is not expressed in bovine, rat and porcine tissues (28). ETB1 encodes an ETBR protein that has an additional 10 amino acids in the second cytoplasmic domain due to alternative splicing of the intron between the second and third exon (28).
The gus-gus mutation is a glycine to aspartic acid substitution at amino acid 371 within TM7.
During embryonic development, Ednrb is expressed in the pre-migratory and migrating neural crest (NC) cells as well as less abundantly in the surrounding mesenchyme (29;30). Ednrb is expressed in human melanoma cell lines; melanoma metastases expressed higher levels of Ednrb when compared to Ednrb expression in primary tumor samples (31).
In mouse and rat, ETBR is expressed in most tissues (22;32) including vascular endothelial cells and vascular smooth muscle cells (VSMCs) (8;33), the cochlea (34), tubular epithelial cells, renal vessels, inner medullary collecting duct (CD), outer medullary CD, cortical CD, and other nephron segments of the kidney (35-38), melanocytes (31), choroid and retina (39;40) as well as the myenteric plexus, mucosal layer, ganglia, and blood vessels of the submucosa of the colon (41-43).
ETBR is localized to the plasma membrane in most cells. However, in subfractionated cardiac membranes, ETBR was localized predominantly to intracellular membranes (44). Confocal microscopy of ventricular myocytes determined that ETBR was localized to the nuclear membrane (44). The nuclear ETBR was able to bind ligands and stimulated an increase in nuclear cisternal calcium content (44). Within the mouse intestine, ETBR is localized to the nuclei of mucosal epithelial cells (45).
The ETB-SVR isoform mRNA is expressed in the lung, placenta, kidney, and skeletal muscle; ETB-SVR mRNA was not expressed in smooth muscle or endothelial cells (18).
There are two ET receptor subtypes expressed in mammals: ETAR and ETBR (4;5;31). A third ET receptor subtype, ETCR, has been identified in Xenopus laevis; a mammalian homologue of ETCR has not been identified (36;46). There are three ET ligands that associate with the ET receptors: ET-1, ET-2, and ET-3. Each of the ET receptors exhibit different affinities for the ET ligands: ETAR has high affinity for ET-1 and ET-2, but low affinity for ET-3; ETCR has higher affinity for ET-3 than for ET-1 and ET-2; while ETBR exhibits equal affinity for all of the ET ligands (4;5;46).
The ET receptors couple to heterotrimeric G-proteins (ETAR: Gq and Gs; ETBR: Gi and Gq) to activate several signaling components including phospholipase D (27;47;48), phospholipase C (PLC; (49;50)), phospholipase A2 (51), cytosolic calcium (52;53), Na+/H+ exchange (54), cGMP production (55), cAMP production (49), tyrosine kinases (56;57), and mitogen-activated protein kinases (MAPKs) (58;59). The ET-activated ET receptors mediate several physiological actions including, but not limited to, vasoconstriction (60), vasodilation (61), activation of DNA synthesis and mitogenesis (62;63), induction of Fos transcription (64), stimulation of phosphatidylinositol (PI) hydrolysis in cerebellar granule cell neurons (63;65), depolarization of spinal neurons (66), and stimulation of substance P release (67). Several ETBR-associated functions are discussed in more detail below.
Development of NC-derived cell lineages
ET-associated signaling (ET-1/ETAR and ET-3/ETBR) is essential for NC cell proliferation, migration, differentiation, and transformation (68-70). The embryonic NC gives rise to pluripotent cells that migrate to different locations within the embryo during development (71). The NC cells subsequently differentiate into several cell types including adrenomedullary cells, craniofacial skeletal tissue, glia and some neurons of the peripheral nervous system, enteric neurons and glia, and melanocytes of the skin, hair and inner ear [reviewed in (71)].
ET-3/ETBR-associated signaling is required between embryonic day (E)10-E12.5 in the mouse for the survival and migration of enteric ganglion neurons and melanocytes derived from trunk/vagal NC cells (1;69;70;72-74). Other studies indicate that ETBR signaling may also stimulate melanocyte proliferation in the epidermis (75). ET-3/ETBR-associated signaling maintains enteric NC-derived cells (ENCCs) in a proliferative state (76;77), inhibits their differentiation (77;78), and is required for the normal migration of ENCCs (73;76).
Four signaling pathways function during melanocyte development: Wnt/β-catenin, MC1R, Kit, and ET-3/ETBR (Figure 3). The Wnt/β-catenin pathway regulates the transcription of microphthalmia transcription factor (Mitf) in NC-derived melanocyte precursors by activating the TCF/Lef1 transcription factor; the transcription factors SOX10 (see the record for Dalmatian) and PAX3 also regulate the expression of melanocyte-specific Mitf [reviewed in (79)]. SOX10 is required for the survival and the maintenance of pluripotency of migrating NC progenitors (80) and also functions in melanocyte differentiation by regulating Tyrp2/Dct (81;82). MITF regulates several target genes to mediate melanocyte survival (Bcl2 and Met; (83;84)), proliferation (e.g., Cdk2 and Tbx2; (85;86)), and differentiation [e.g., Tyr (see the record for ghost), Tyrp1 (see the record for chi), Slc45a2 (see the record for cardigan), Dct, Pmel, and Mc1r (see the record for deer); reviewed in (87)]. Melanocyte stimulating hormone (MSH)-mediated activation of the melanocortin 1 receptor (MC1R) elevates cyclic-AMP levels to subsequently activate MAP kinase pathways and increase Mitf and Sox10 promoter activities as well as activates the CREB family of transcription factors (88;89). ET-3 (or ET-1)/ETBR signaling activates a phosphatidylinositol-calcium second messenger system following binding and activation of G proteins (Figure 4). The GTP-bound Gα-q subunit activates phospholipase Cβ (PLCβ), leading to the hydrolysis of Ptdins(4,5)P2 and the production of diacylglycerol (DAG) and inositol trisphosphate (IP3) (90). IP3 leads to the mobilization of Ca2+ in the cytosol, while the DAG and cytosolic Ca2+ activate RAS-related protein-1a (RAP-1A), a member of the RAS oncogene family. Activated RAP-1A activates v-raf murine sarcoma viral oncogene homolog B1 (B-Raf). DAG also activates the PKCε/H-Ras/and C-Raf1 pathway (91). B-Raf and/or C-Raf1 phosphorylate and activate MEK1 and MEK2, which subsequently phosphorylate ERK1/2 (91). ERK1/2 induces the activation of the p90 ribosomal S6 kinase (p90Rsk). The activation of the p90Rsk proteins leads to the phosphorylation of cAMP responsive element binding protein 1 (CREB1) and activating transcription factor 1 (ATF-1) (92;93). The transcriptional activity of ATF-1 and CREB1 induces cFos expression and subsequent cellular proliferation and migration as well as the induction of the Mitf promoter during melanocyte development. The Kit (see the record for Pretty2) and ET-3/ETBR signaling pathways merge at the level of Ras activation and subsequently induce the phosphorylation of MITF in mature melanocytes. ET-3/ETBR directly or indirectly maintains Sox10 expression and/or modulates SOX10 activity (71). Stanchina et al. propose that SOX10 and the ET-3/ETBR signaling pathway cooperate for the development of the enteric nervous system and melanocytic NC cell lineage (71). See the “Vasodilation” section for additional information about ETBR signaling.
Using a NC cell-specific Ednrb knockout (NCC ETB KO) mouse model, Zaitoun et al. determined that ganglia are absent from the distal third of the NCC ETB KO colon, and are decreased in number and size in the proximal and distal mid-colon (74). In the ganglionated region of the NCC ETB KO colons, there was an increase in vasoactive intestinal polypeptide (VIP) and nitric oxide synthase (nNOS) with a concomitant decrease in choline acetyltransferase (ChAT) in comparison to the wild-type mouse; these molecules in the enteric ganglia regulate motility of the gut (74). The expression of nNOS, VIP, and ChAT were inversely related to neuronal density (74).
In ENCCs, the RET receptor tyrosine kinase is activated by the glial cell-line-derived neurotrophic factor (GDNF) and GDNF family receptor α1 (GFRα1) complex [reviewed in (94)]. RET-associated signaling promotes the survival, proliferation, migration, and differentiation of enteric neurons through the activation of Akt, ERK and MAPK P38 [(95-97); reviewed in (94)]. In vitro and in vivo studies have demonstrated crosstalk between the RET and ET-3/ETBR signaling pathways during enteric nervous system development, however the molecular bases of this crosstalk is unknown (76;98;99).
ET-1-mediated activation of ETAR and/or ETBR on vascular smooth muscle cells (VSMCs) induces vasoconstriction and VSMC proliferation (100). During vasoconstriction, ET-1/ETBR and/or ET-1/ETAR stimulate the phosphorylation of ERK1/2 (Figure 4; (101)). ERK1/2 is a known regulator of cellular proliferation, differentiation, migration, and vasoconstriction (34;101).
ET-1/ETBR-associated signaling also promotes stretch-induced apoptosis in cultured VSMCs, and may thereby possibly play a role during hypertension-induced remodeling in conduit arteries (102). In an Ednrb knockout (Ednrb-/-) mouse with complete ligation of the right common carotid artery, vascular remodeling was accelerated while the levels of nitric oxide (NO; a component of the dilator response) release were decreased compared to wild-type mice (103). Murakoshi et al. propose that the loss of ETBR-mediated apoptosis of VSMCs leads to neointimal hyperplasia (i.e., thickening of the blood vessel) and vascular stenosis (i.e., abnormal narrowing of the blood vessels) in the proximal carotid artery of the Ednrb-/- mouse after ligation (103). They also suggest that a decrease in endothelium-derived relaxation factors and NO may enhance vascular remodeling in the KO mice after ligation (103).
The ET-1 ligand is elevated in patients with hypertension and is considered a key mediator of hypertension (60). ETBR mediates the clearance of circulating ET-1 by tightly binding the ligand and transporting it into lysosomal compartments (104-106). The endocytosed ET-1 subsequently negatively regulates ET-1 gene transcription (107). The decrease in circulating ET-1 also reduces the amount of ET-1 that can interact with ETAR, subsequently leading to a decrease in ETAR-mediated vascular contraction (106;108).
ETBR-associated signaling can also induce vasodilation (33). Vascular endothelial cells (ECs) exclusively express ETBR, which mediates vasodilation upon ET-1 or ET-3-associated ETBR activation (109;110). Mechanistically, ET-1 or ET-3-induced ETBR activation promotes Gβγ dissociation from the Gαi subunit of the heterotrimeric G-protein (Figure 4). The dissociated Gβγ subsequently activates phosphatidylinositol 3 kinase (PI3K) to produce PtdIns(3,4,5)P3 (PI(3,4,5)P3). PI(3,4,5)P3 recruits and activates AKT, which subsequently phosphorylates eNOS, leading to increased NO production, the release of prostacyclin (a vasodilator and inhibitor of platelet aggregation), and vasodilation (103;111-113). In an EC-specific Ednrb knockout mouse (EC ETB KO), ETBR-mediated vasodilation was impaired and the plasma concentration of ET-1 was increased; other ETBR-mediated functions in non-ECs (i.e., enteric nervous system development and pigmentation) were not affected (114).
Regulation of natriuresis and diuresis
ETBR-associated signaling in the medullary CD, outer medullary CD, and cortical CD regulates systemic blood pressure (36). ET-1/ETBR-associated signaling reduces vasopressin-stimulated cAMP accumulation (115-117) and osmotic water permeability (118;119) in the CD. CD-specific knockout of Ednrb (CD ETB KO) resulted in hypertension on a normal-sodium diet, which was further exacerbated on a chronic high-sodium diet; the mice had no other gross morphological abnormalities (36). Upon acute sodium loading, the CD ETB KO mice exhibited impaired sodium excretion (36). CD-derived ET-1 functions through the activation of ETBR to promote natriuresis (excretion of sodium in the urine) and diuresis (urine production by the kidney) to subsequently lower blood pressure (120-123). Interestingly, CD-specific ET-1 knockout mice displayed more severe hypertension than CD ETB KO mice, suggesting that ET-1 may also signal in a paracrine manner to ETBR and ETAR outside the CD to regulate natriuresis and diuresis (36).
Inflammatory pain and cutaneous inflammation
Inflammatory pain, tissue swelling, and neutrophil infiltration are mediated by ET-1/ETBR-associated signaling (124). An Ednrb knockout mouse was treated with pharmacological agents phenylbenzoquinone (induces algesia, a sensitivity to inflammatory pain) and arachidonic acid (induces pruritus and cutaneous inflammation) (124). The Ednrb null mice did not display sensitivity to inflammatory pain when compared to wild-type mice; noninflammatory pain was equivalent between the null and wild type mice (124). In addition, null and heterozygous mice exhibited reduced arachidonic acid-induced cutaneous inflammatory responses and neutrophil infiltration compared to wild-type mice (124).
Human diseases associated with ETBR defects
Mutations in EDNRB are linked to several diseases including ABCD syndrome [OMIM: #600501; (125)], Waardenburg syndrome type 4A [WS4A; OMIM: #277580; (126)], and susceptibility to Hirschsprung disease 2 [HSCR2; OMIM: #600155; (10;126;127)]. Patients with ABCD syndrome exhibit albinism, retinal depigmentation, bilateral deafness, and aganglionosis of the large intestine together with total absence of neurocytes and nerve fibers in the small intestine (125). Patients with WS4A also exhibit pigment abnormalities of the hair, skin, and eyes due to a lack of melanocytes, and congenital sensorineural hearing loss due to a lack of melanocytes in the cochlea, as well as Hirschsprung disease, a congenital absence of ganglion cells distal portion of the gastrointestinal tract (10;126-128).
A link between ETBR-associated signaling and melanoma has been described [reviewed in (92)]. Increased EDNRB expression has been detected in melanoma metastases (compared to primary tumors) (129). EDNRB mutations that impair ETBR function have been detected in melanoma patients (130).
Mice homozygous for targeted as well as naturally occurring Ednrb null mutations (e.g., MGI:1856148, MGI:1856149, MGI:1857161, and MGI:3795226) exhibit a piebald appearance due to the absence of NC-derived melanocytes in the epidermis (1;73;114;128;131-133). Ednrb null mice also exhibit an absence of choroidal melanocytes; neuroectoderm-derived pigment epithelium melanocytes develop normally (1). Ednrb null mice display early postnatal lethality [from ~postnatal day 15 to up to seven weeks after birth; (1;114;128;133)], distended and aganglionic colon [i.e., megacolon; (1;73;128;133;134)], reduced inflammatory response to topical application of arachidonic acid (124), and deafness due to a loss of strial intermediate cells and degeneration of the organ of Corti (128). A naturally occurring deletion in ETBR occurs in the spotting lethal (sl) rat model (135). Similar to the mouse models described above, homozygous sl rats exhibit abnormal epidermal melanocyte and enteric nervous system development as well as premature postnatal death following intestinal aganglionosis and obstruction (135). Homozygous sl rats that express a dopamine-β-hydroxylase-ETBR transgene (ETBR is expressed in the adrenal glands and other adrenergic neurons) survive to adulthood and exhibit normal enteric development (121;136). The sl rats that express the ETBR transgene are deficient in ETBR expression in the kidney, vascular endothelium, and vascular smooth muscle; they did not exhibit vasoconstriction, vasodilation, or diuretic action (135).
Similar to spontaneous and targeted Ednrb knockout mouse models, the gus-gus mice exhibit a piebald appearance and early postnatal lethality. The Ednrb knockout mouse models have established that the observed pigmentation defects are due to the absence of NC-derived melanocytes in the hair bulbs of non-pigmented areas (1;73;114;128;131-133). Other phenotypes associated with Ednrb deficiency have not been examined in the gus-gus mouse.
gus-gus(F):5'- CCCATCACATATATCGCAAGGCAGG -3'
gus-gus(R):5'- CCTCCCTCGCTTCCAAATGAGAATC -3'
gus-gus_seq(F):5'- GGGAAAATTAGCAATCTTCCAGCTC -3'
gus-gus_seq(R):5'- gacagacggagaaagagacag -3'
Gus-gus genotyping is performed by amplifying the region containing the mutation using PCR, followed by sequencing of the amplified region to detect the single nucleotide transition.
Gus-gus(F): 5’- CCCATCACATATATCGCAAGGCAGG -3’
Gus-gus(R): 5’- CCTCCCTCGCTTCCAAATGAGAATC -3’
Gus-gus_seq(F): 5’- GGGAAAATTAGCAATCTTCCAGCTC -3’
1) 94°C 2:00
2) 94°C 0:30
3) 55°C 0:30
4) 72°C 1:00
5) repeat steps (2-4) 40X
6) 72°C 10:00
7) 4°C ∞
The following sequence of 517 nucleotides is amplified (Chr.14: 103819795-103820311, GRCm38):
1 cccatcacat atatcgcaag gcagggaaaa ttagcaatct tccagctctc tctagatagc
61 aatattggtg tgttttttaa agcctatatt tgatgccaga tcacaggaaa cattttattt
121 tagaagagtt tcttacctta aagcagtttt tgaatctttt gctcaccaaa tacagagcga
181 ttggattgat gcaggagttc aaagaagcca tgttgatacc aatgtagtcc aaaaccaaca
241 aaaagctgaa agaaacccaa agttgtcttt aaagattaca tccctccaag tgtgtattta
301 acttgcacct ttatgttttt atgaagaaag cccaaatcac ctacatgcaa taattttatt
361 tagccactga tttaccagca gaggtgcctg tctgtgtctc tgcctgcctg tctctttctc
421 cgtctgtctt tggcatctcc actgccctat cccaccttca ccaccaatat gcagcatttc
481 ttttaaaaat aagattctca tttggaagcg agggagg
Primer binding sites are underlined and the sequencing primer is highlighted; the mutated nucleotide is shown in red text (C>T, Chr. + strand; G>A, sense strand).
1. Hosoda, K., Hammer, R. E., Richardson, J. A., Baynash, A. G., Cheung, J. C., Giaid, A., and Yanagisawa, M. (1994) Targeted and Natural (Piebald-Lethal) Mutations of Endothelin-B Receptor Gene Produce Megacolon Associated with Spotted Coat Color in Mice. Cell. 79, 1267-1276.
2. Ogawa, Y., Nakao, K., Arai, H., Nakagawa, O., Hosoda, K., Suga, S., Nakanishi, S., and Imura, H. (1991) Molecular Cloning of a Non-Isopeptide-Selective Human Endothelin Receptor. Biochem Biophys Res Commun. 178, 248-255.
3. Nakamuta, M., Takayanagi, R., Sakai, Y., Sakamoto, S., Hagiwara, H., Mizuno, T., Saito, Y., Hirose, S., Yamamoto, M., and Nawata, H. (1991) Cloning and Sequence Analysis of a cDNA Encoding Human Non-Selective Type of Endothelin Receptor. Biochem Biophys Res Commun. 177, 34-39.
4. Arai, H., Hori, S., Aramori, I., Ohkubo, H., and Nakanishi, S. (1990) Cloning and Expression of a cDNA Encoding an Endothelin Receptor. Nature. 348, 730-732.
5. Sakurai, T., Yanagisawa, M., Takuwa, Y., Miyazaki, H., Kimura, S., Goto, K., and Masaki, T. (1990) Cloning of a cDNA Encoding a Non-Isopeptide-Selective Subtype of the Endothelin Receptor. Nature. 348, 732-735.
6. Kochl, R., Alken, M., Rutz, C., Krause, G., Oksche, A., Rosenthal, W., and Schulein, R. (2002) The Signal Peptide of the G Protein-Coupled Human Endothelin B Receptor is Necessary for Translocation of the N-Terminal Tail Across the Endoplasmic Reticulum Membrane. J Biol Chem. 277, 16131-16138.
7. Saito, Y., Mizuno, T., Itakura, M., Suzuki, Y., Ito, T., Hagiwara, H., and Hirose, S. (1991) Primary Structure of Bovine Endothelin ETB Receptor and Identification of Signal Peptidase and Metal Proteinase Cleavage Sites. J Biol Chem. 266, 23433-23437.
8. Grantcharova, E., Furkert, J., Reusch, H. P., Krell, H. W., Papsdorf, G., Beyermann, M., Schulein, R., Rosenthal, W., and Oksche, A. (2002) The Extracellular N Terminus of the Endothelin B (ETB) Receptor is Cleaved by a Metalloprotease in an Agonist-Dependent Process. J Biol Chem. 277, 43933-43941.
9. Kozuka, M., Ito, T., Hirose, S., Lodhi, K. M., and Hagiwara, H. (1991) Purification and Characterization of Bovine Lung Endothelin Receptor. J Biol Chem. 266, 16892-16896.
10. Tanaka, H., Moroi, K., Iwai, J., Takahashi, H., Ohnuma, N., Hori, S., Takimoto, M., Nishiyama, M., Masaki, T., Yanagisawa, M., Sekiya, S., and Kimura, S. (1998) Novel Mutations of the Endothelin B Receptor Gene in Patients with Hirschsprung's Disease and their Characterization. J Biol Chem. 273, 11378-11383.
11. Takasuka, T., Sakurai, T., Goto, K., Furuichi, Y., and Watanabe, T. (1994) Human Endothelin Receptor ETB. Amino Acid Sequence Requirements for Super Stable Complex Formation with its Ligand. J Biol Chem. 269, 7509-7513.
12. Waggoner, W. G., Genova, S. L., and Rash, V. A. (1992) Kinetic Analyses Demonstrate that the Equilibrium Assumption does Not Apply to [125I]Endothelin-1 Binding Data. Life Sci. 51, 1869-1876.
13. Akiyama, N., Hiraoka, O., Fujii, Y., Terashima, H., Satoh, M., Wada, K., and Furuichi, Y. (1992) Biotin Derivatives of Endothelin: Utilization for Affinity Purification of Endothelin Receptor. Protein Expr Purif. 3, 427-433.
14. Oksche, A., Boese, G., Horstmeyer, A., Furkert, J., Beyermann, M., Bienert, M., and Rosenthal, W. (2000) Late endosomal/lysosomal Targeting and Lack of Recycling of the Ligand-Occupied Endothelin B Receptor. Mol Pharmacol. 57, 1104-1113.
15. Mazzuca, M. Q., and Khalil, R. A. (2012) Vascular Endothelin Receptor Type B: Structure, Function and Dysregulation in Vascular Disease. Biochem Pharmacol. 84, 147-162.
16. Sakamoto, A., Yanagisawa, M., Sawamura, T., Enoki, T., Ohtani, T., Sakurai, T., Nakao, K., Toyo-oka, T., and Masaki, T. (1993) Distinct Subdomains of Human Endothelin Receptors Determine their Selectivity to endothelinA-Selective Antagonist and endothelinB-Selective Agonists. J Biol Chem. 268, 8547-8553.
17. Wada, K., Hashido, K., Terashima, H., Adachi, M., Fujii, Y., Hiraoka, O., Furuichi, Y., and Miyamoto, C. (1995) Ligand Binding Domain of the Human Endothelin-B Subtype Receptor. Protein Expr Purif. 6, 228-236.
18. Elshourbagy, N. A., Adamou, J. E., Gagnon, A. W., Wu, H. L., Pullen, M., and Nambi, P. (1996) Molecular Characterization of a Novel Human Endothelin Receptor Splice Variant. J Biol Chem. 271, 25300-25307.
19. Laghmani, K., Sakamoto, A., Yanagisawa, M., Preisig, P. A., and Alpern, R. J. (2005) A Consensus Sequence in the Endothelin-B Receptor Second Intracellular Loop is Required for NHE3 Activation by Endothelin-1. Am J Physiol Renal Physiol. 288, F732-9.
20. Abe, Y., Nakayama, K., Yamanaka, A., Sakurai, T., and Goto, K. (2000) Subtype-Specific Trafficking of Endothelin Receptors. J Biol Chem. 275, 8664-8671.
21. Paasche, J. D., Attramadal, T., Sandberg, C., Johansen, H. K., and Attramadal, H. (2001) Mechanisms of Endothelin Receptor Subtype-Specific Targeting to Distinct Intracellular Trafficking Pathways. J Biol Chem. 276, 34041-34050.
22. Elshourbagy, N. A., Korman, D. R., Wu, H. L., Sylvester, D. R., Lee, J. A., Nuthalaganti, P., Bergsma, D. J., Kumar, C. S., and Nambi, P. (1993) Molecular Characterization and Regulation of the Human Endothelin Receptors. J Biol Chem. 268, 3873-3879.
23. Stannard, C., Lehenkari, P., and Godovac-Zimmermann, J. (2003) Functional Diversity of Endothelin Pathways in Human Lung Fibroblasts may be Based on Structural Diversity of the Endothelin Receptors. Biochemistry. 42, 13909-13918.
24. Okamoto, Y., Ninomiya, H., Tanioka, M., Sakamoto, A., Miwa, S., and Masaki, T. (1997) Palmitoylation of Human endothelinB. its Critical Role in G Protein Coupling and a Differential Requirement for the Cytoplasmic Tail by G Protein Subtypes. J Biol Chem. 272, 21589-21596.
25. Karnik, S. S., and Khorana, H. G. (1990) Assembly of Functional Rhodopsin Requires a Disulfide Bond between Cysteine Residues 110 and 187. J Biol Chem. 265, 17520-17524.
26. Masaki, T., Ninomiya, H., Sakamoto, A., and Okamoto, Y. (1999) Structural Basis of the Function of Endothelin Receptor. Mol Cell Biochem. 190, 153-156.
27. Aramori, I., and Nakanishi, S. (1992) Coupling of Two Endothelin Receptor Subtypes to Differing Signal Transduction in Transfected Chinese Hamster Ovary Cells. J Biol Chem. 267, 12468-12474.
28. Shyamala, V., Moulthrop, T. H., Stratton-Thomas, J., and Tekamp-Olson, P. (1994) Two Distinct Human Endothelin B Receptors Generated by Alternative Splicing from a Single Gene. Cell Mol Biol Res. 40, 285-296.
29. Nataf, V., Lecoin, L., Eichmann, A., and Le Douarin, N. M. (1996) Endothelin-B Receptor is Expressed by Neural Crest Cells in the Avian Embryo. Proc Natl Acad Sci U S A. 93, 9645-9650.
30. Brand, M., Le Moullec, J. M., Corvol, P., and Gasc, J. M. (1998) Ontogeny of Endothelins-1 and -3, their Receptors, and Endothelin Converting Enzyme-1 in the Early Human Embryo. J Clin Invest. 101, 549-559.
31. Scarparo, A. C., Isoldi, M. C., de Lima, L. H., Visconti, M. A., and Castrucci, A. M. (2007) Expression of Endothelin Receptors in Frog, Chicken, Mouse and Human Pigment Cells. Comp Biochem Physiol A Mol Integr Physiol. 147, 640-646.
32. Adur, J., Uchide, T., Takizawa, S., Quan, J., and Saida, K. (2004) Real-Time Polymerase Chain Reaction Quantification of Gene Expression Levels of Murine Endothelin-A and Endothelin-B Receptors: Gene Expression Profiles by the Standard Curve Method. J Cardiovasc Pharmacol. 44 Suppl 1, S321-8.
33. Clozel, M., Gray, G. A., Breu, V., Loffler, B. M., and Osterwalder, R. (1992) The Endothelin ETB Receptor Mediates both Vasodilation and Vasoconstriction in Vivo. Biochem Biophys Res Commun. 186, 867-873.
34. Luo, G., Jamali, R., Cao, Y. X., Edvinsson, L., and Xu, C. B. (2006) Vascular Endothelin ET(B) Receptor-Mediated Contraction Requires Phosphorylation of ERK1/2 Proteins. Eur J Pharmacol. 538, 124-131.
35. Terada, Y., Tomita, K., Nonoguchi, H., and Marumo, F. (1992) Different Localization of Two Types of Endothelin Receptor mRNA in Microdissected Rat Nephron Segments using Reverse Transcription and Polymerase Chain Reaction Assay. J Clin Invest. 90, 107-112.
36. Ge, Y., Bagnall, A., Stricklett, P. K., Strait, K., Webb, D. J., Kotelevtsev, Y., and Kohan, D. E. (2006) Collecting Duct-Specific Knockout of the Endothelin B Receptor Causes Hypertension and Sodium Retention. Am J Physiol Renal Physiol. 291, F1274-80.
37. Chow, L. H., Subramanian, S., Nuovo, G. J., Miller, F., and Nord, E. P. (1995) Endothelin Receptor mRNA Expression in Renal Medulla Identified by in Situ RT-PCR. Am J Physiol. 269, F449-57.
38. Kohan, D. E., Hughes, A. K., and Perkins, S. L. (1992) Characterization of Endothelin Receptors in the Inner Medullary Collecting Duct of the Rat. J Biol Chem. 267, 12336-12340.
39. MacCumber, M. W., and D'Anna, S. A. (1994) Endothelin Receptor-Binding Subtypes in the Human Retina and Choroid. Arch Ophthalmol. 112, 1231-1235.
40. Stitt, A. W., Chakravarthy, U., Gardiner, T. A., and Archer, D. B. (1996) Endothelin-Like Immunoreactivity and Receptor Binding in the Choroid and Retina. Curr Eye Res. 15, 111-117.
41. Inagaki, H., Bishop, A. E., Escrig, C., Wharton, J., Allen-Mersh, T. G., and Polak, J. M. (1991) Localization of Endothelinlike Immunoreactivity and Endothelin Binding Sites in Human Colon. Gastroenterology. 101, 47-54.
42. Sakamoto, A., Yanagisawa, M., Sakurai, T., Takuwa, Y., Yanagisawa, H., and Masaki, T. (1991) Cloning and Functional Expression of Human cDNA for the ETB Endothelin Receptor. Biochem Biophys Res Commun. 178, 656-663.
43. Yoshimura, M., Yamashita, Y., Kan, S., Niwa, M., and Taniyama, K. (1996) Localization of Endothelin ETB Receptors on the Myenteric Plexus of Guinea-Pig Ileum and the Receptor-Mediated Release of Acetylcholine. Br J Pharmacol. 118, 1171-1176.
44. Boivin, B., Chevalier, D., Villeneuve, L. R., Rousseau, E., and Allen, B. G. (2003) Functional Endothelin Receptors are Present on Nuclei in Cardiac Ventricular Myocytes. J Biol Chem. 278, 29153-29163.
45. Takizawa, S., Uchide, T., Kozakai, T., Adur, J., Quan, J., and Saida, K. (2004) Immunolocalization of Endothelin-B Receptor in Mouse Intestinal Tract. J Cardiovasc Pharmacol. 44 Suppl 1, S329-31.
46. Karne, S., Jayawickreme, C. K., and Lerner, M. R. (1993) Cloning and Characterization of an Endothelin-3 Specific Receptor (ETC Receptor) from Xenopus Laevis Dermal Melanophores. J Biol Chem. 268, 19126-19133.
47. Friedlaender, M. M., Jain, D., Ahmed, Z., Hart, D., Barnett, R. L., and Nord, E. P. (1993) Endothelin Activation of Phospholipase D: Dual Modulation by Protein Kinase C and Ca2+. Am J Physiol. 264, F845-53.
48. Liu, Y., Geisbuhler, B., and Jones, A. W. (1992) Activation of Multiple Mechanisms Including Phospholipase D by Endothelin-1 in Rat Aorta. Am J Physiol. 262, C941-9.
49. Hilal-Dandan, R., Urasawa, K., and Brunton, L. L. (1992) Endothelin Inhibits Adenylate Cyclase and Stimulates Phosphoinositide Hydrolysis in Adult Cardiac Myocytes. J Biol Chem. 267, 10620-10624.
50. Ambar, I., and Sokolovsky, M. (1993) Endothelin Receptors Stimulate both Phospholipase C and Phospholipase D Activities in Different Cell Lines. Eur J Pharmacol. 245, 31-41.
51. Husain, S., and Abdel-Latif, A. A. (1998) Role of Protein Kinase C Alpha in Endothelin-1 Stimulation of Cytosolic Phospholipase A2 and Arachidonic Acid Release in Cultured Cat Iris Sphincter Smooth Muscle Cells. Biochim Biophys Acta. 1392, 127-144.
52. van Heugten, H. A., de Jonge, H. W., Bezstarosti, K., and Lamers, J. M. (1994) Calcium and the Endothelin-1 and Alpha 1-Adrenergic Stimulated Phosphatidylinositol Cycle in Cultured Rat Cardiomyocytes. J Mol Cell Cardiol. 26, 1081-1093.
53. Pollock, D. M., Keith, T. L., and Highsmith, R. F. (1995) Endothelin Receptors and Calcium Signaling. FASEB J. 9, 1196-1204.
54. Ballard, C., and Schaffer, S. (1996) Stimulation of the Na+/Ca2+ Exchanger by Phenylephrine, Angiotensin II and Endothelin 1. J Mol Cell Cardiol. 28, 11-17.
55. Fujitani, Y., Ueda, H., Okada, T., Urade, Y., and Karaki, H. (1993) A Selective Agonist of Endothelin Type B Receptor, IRL 1620, Stimulates Cyclic GMP Increase Via Nitric Oxide Formation in Rat Aorta. J Pharmacol Exp Ther. 267, 683-689.
56. Sadoshima, J., Qiu, Z., Morgan, J. P., and Izumo, S. (1995) Angiotensin II and Other Hypertrophic Stimuli Mediated by G Protein-Coupled Receptors Activate Tyrosine Kinase, Mitogen-Activated Protein Kinase, and 90-kD S6 Kinase in Cardiac Myocytes. the Critical Role of Ca(2+)-Dependent Signaling. Circ Res. 76, 1-15.
57. Simonson, M. S., and Herman, W. H. (1993) Protein Kinase C and Protein Tyrosine Kinase Activity Contribute to Mitogenic Signaling by Endothelin-1. Cross-Talk between G Protein-Coupled Receptors and pp60c-Src. J Biol Chem. 268, 9347-9357.
58. Bogoyevitch, M. A., Glennon, P. E., Andersson, M. B., Clerk, A., Lazou, A., Marshall, C. J., Parker, P. J., and Sugden, P. H. (1994) Endothelin-1 and Fibroblast Growth Factors Stimulate the Mitogen-Activated Protein Kinase Signaling Cascade in Cardiac Myocytes. the Potential Role of the Cascade in the Integration of Two Signaling Pathways Leading to Myocyte Hypertrophy. J Biol Chem. 269, 1110-1119.
59. Bogoyevitch, M. A., Glennon, P. E., and Sugden, P. H. (1993) Endothelin-1, Phorbol Esters and Phenylephrine Stimulate MAP Kinase Activities in Ventricular Cardiomyocytes. FEBS Lett. 317, 271-275.
60. Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y., Kobayashi, M., Mitsui, Y., Yazaki, Y., Goto, K., and Masaki, T. (1988) A Novel Potent Vasoconstrictor Peptide Produced by Vascular Endothelial Cells. Nature. 332, 411-415.
61. Hoffman, A., Grossman, E., Ohman, K. P., Marks, E., and Keiser, H. R. (1990) The Initial Vasodilation and the Later Vasoconstriction of Endothelin-1 are Selective to Specific Vascular Beds. Am J Hypertens. 3, 789-791.
62. Takuwa, N., Takuwa, Y., Yanagisawa, M., Yamashita, K., and Masaki, T. (1989) A Novel Vasoactive Peptide Endothelin Stimulates Mitogenesis through Inositol Lipid Turnover in Swiss 3T3 Fibroblasts. J Biol Chem. 264, 7856-7861.
63. MacCumber, M. W., Ross, C. A., and Snyder, S. H. (1990) Endothelin in Brain: Receptors, Mitogenesis, and Biosynthesis in Glial Cells. Proc Natl Acad Sci U S A. 87, 2359-2363.
64. Komuro, I., Kurihara, H., Sugiyama, T., Yoshizumi, M., Takaku, F., and Yazaki, Y. (1988) Endothelin Stimulates c-Fos and c-Myc Expression and Proliferation of Vascular Smooth Muscle Cells. FEBS Lett. 238, 249-252.
65. Lysko, P. G., Feuerstein, G., Pullen, M., Wu, H. L., and Nambi, P. (1991) Identification of Endothelin Receptors in Cultured Cerebellar Neurons. Neuropeptides. 18, 83-86.
66. Yoshizawa, T., Kimura, S., Kanazawa, I., Yanagisawa, M., and Masaki, T. (1989) Endothelin-1 Depolarizes a Ventral Root Potential in the Newborn Rat Spinal Cord. J Cardiovasc Pharmacol. 13 Suppl 5, S216-7.
67. Yoshizawa, T., Kimura, S., Kanazawa, I., Uchiyama, Y., Yanagisawa, M., and Masaki, T. (1989) Endothelin Localizes in the Dorsal Horn and Acts on the Spinal Neurones: Possible Involvement of Dihydropyridine-Sensitive Calcium Channels and Substance P Release. Neurosci Lett. 102, 179-184.
68. Pla, P., and Larue, L. (2003) Involvement of Endothelin Receptors in Normal and Pathological Development of Neural Crest Cells. Int J Dev Biol. 47, 315-325.
69. Shin, M. K., Levorse, J. M., Ingram, R. S., and Tilghman, S. M. (1999) The Temporal Requirement for Endothelin Receptor-B Signalling during Neural Crest Development. Nature. 402, 496-501.
70. Kurihara, H., Kurihara, Y., Nagai, R., and Yazaki, Y. (1999) Endothelin and Neural Crest Development. Cell Mol Biol (Noisy-le-grand). 45, 639-651.
71. Stanchina, L., Baral, V., Robert, F., Pingault, V., Lemort, N., Pachnis, V., Goossens, M., and Bondurand, N. (2006) Interactions between Sox10, Edn3 and Ednrb during Enteric Nervous System and Melanocyte Development. Dev Biol. 295, 232-249.
72. Baynash, A. G., Hosoda, K., Giaid, A., Richardson, J. A., Emoto, N., Hammer, R. E., and Yanagisawa, M. (1994) Interaction of Endothelin-3 with Endothelin-B Receptor is Essential for Development of Epidermal Melanocytes and Enteric Neurons. Cell. 79, 1277-1285.
73. Lee, H. O., Levorse, J. M., and Shin, M. K. (2003) The Endothelin Receptor-B is Required for the Migration of Neural Crest-Derived Melanocyte and Enteric Neuron Precursors. Dev Biol. 259, 162-175.
74. Zaitoun, I., Erickson, C. S., Barlow, A. J., Klein, T. R., Heneghan, A. F., Pierre, J. F., Epstein, M. L., and Gosain, A. (2013) Altered Neuronal Density and Neurotransmitter Expression in the Ganglionated Region of Ednrb Null Mice: Implications for Hirschsprung's Disease. Neurogastroenterol Motil. 25, e233-44.
75. Yoshida, H., Kunisada, T., Kusakabe, M., Nishikawa, S., and Nishikawa, S. I. (1996) Distinct Stages of Melanocyte Differentiation Revealed by Anlaysis of Nonuniform Pigmentation Patterns. Development. 122, 1207-1214.
76. Barlow, A., de Graaff, E., and Pachnis, V. (2003) Enteric Nervous System Progenitors are Coordinately Controlled by the G Protein-Coupled Receptor EDNRB and the Receptor Tyrosine Kinase RET. Neuron. 40, 905-916.
77. Bondurand, N., Natarajan, D., Barlow, A., Thapar, N., and Pachnis, V. (2006) Maintenance of Mammalian Enteric Nervous System Progenitors by SOX10 and Endothelin 3 Signalling. Development. 133, 2075-2086.
78. Nagy, N., and Goldstein, A. M. (2006) Endothelin-3 Regulates Neural Crest Cell Proliferation and Differentiation in the Hindgut Enteric Nervous System. Dev Biol. 293, 203-217.
79. Hou, L., and Pavan, W. J. (2008) Transcriptional and Signaling Regulation in Neural Crest Stem Cell-Derived Melanocyte Development: Do all Roads Lead to Mitf? Cell Res. 18, 1163-1176.
80. Kim, J., Lo, L., Dormand, E., and Anderson, D. J. (2003) SOX10 Maintains Multipotency and Inhibits Neuronal Differentiation of Neural Crest Stem Cells. Neuron. 38, 17-31.
81. Bondurand, N., Pingault, V., Goerich, D. E., Lemort, N., Sock, E., Le Caignec, C., Wegner, M., and Goossens, M. (2000) Interaction among SOX10, PAX3 and MITF, Three Genes Altered in Waardenburg Syndrome. Hum Mol Genet. 9, 1907-1917.
82. Jiao, Z., Mollaaghababa, R., Pavan, W. J., Antonellis, A., Green, E. D., and Hornyak, T. J. (2004) Direct Interaction of Sox10 with the Promoter of Murine Dopachrome Tautomerase (Dct) and Synergistic Activation of Dct Expression with Mitf. Pigment Cell Res. 17, 352-362.
83. McGill, G. G., Haq, R., Nishimura, E. K., and Fisher, D. E. (2006) C-Met Expression is Regulated by Mitf in the Melanocyte Lineage. J Biol Chem. 281, 10365-10373.
84. McGill, G. G., Horstmann, M., Widlund, H. R., Du, J., Motyckova, G., Nishimura, E. K., Lin, Y. L., Ramaswamy, S., Avery, W., Ding, H. F., Jordan, S. A., Jackson, I. J., Korsmeyer, S. J., Golub, T. R., and Fisher, D. E. (2002) Bcl2 Regulation by the Melanocyte Master Regulator Mitf Modulates Lineage Survival and Melanoma Cell Viability. Cell. 109, 707-718.
85. Carreira, S., Liu, B., and Goding, C. R. (2000) The Gene Encoding the T-Box Factor Tbx2 is a Target for the Microphthalmia-Associated Transcription Factor in Melanocytes. J Biol Chem. 275, 21920-21927.
86. Du, J., Widlund, H. R., Horstmann, M. A., Ramaswamy, S., Ross, K., Huber, W. E., Nishimura, E. K., Golub, T. R., and Fisher, D. E. (2004) Critical Role of CDK2 for Melanoma Growth Linked to its Melanocyte-Specific Transcriptional Regulation by MITF. Cancer Cell. 6, 565-576.
87. Goding, C. R. (2000) Melanocyte Development and Malignant Melanoma. Forum (Genova). 10, 176-187.
88. Hemesath, T. J., Price, E. R., Takemoto, C., Badalian, T., and Fisher, D. E. (1998) MAP Kinase Links the Transcription Factor Microphthalmia to c-Kit Signalling in Melanocytes. Nature. 391, 298-301.
89. Price, E. R., Horstmann, M. A., Wells, A. G., Weilbaecher, K. N., Takemoto, C. M., Landis, M. W., and Fisher, D. E. (1998) Alpha-Melanocyte-Stimulating Hormone Signaling Regulates Expression of Microphthalmia, a Gene Deficient in Waardenburg Syndrome. J Biol Chem. 273, 33042-33047.
90. Kasuya, Y., Abe, Y., Hama, H., Sakurai, T., Asada, S., Masaki, T., and Goto, K. (1994) Endothelin-1 Activates Mitogen-Activated Protein Kinases through Two Independent Signalling Pathways in Rat Astrocytes. Biochem Biophys Res Commun. 204, 1325-1333.
91. Schinelli, S., Zanassi, P., Paolillo, M., Wang, H., Feliciello, A., and Gallo, V. (2001) Stimulation of Endothelin B Receptors in Astrocytes Induces cAMP Response Element-Binding Protein Phosphorylation and c-Fos Expression Via Multiple Mitogen-Activated Protein Kinase Signaling Pathways. J Neurosci. 21, 8842-8853.
92. Saldana-Caboverde, A., and Kos, L. (2010) Roles of Endothelin Signaling in Melanocyte Development and Melanoma. Pigment Cell Melanoma Res. 23, 160-170.
93. Imokawa, G., Yada, Y., and Kimura, M. (1996) Signalling Mechanisms of Endothelin-Induced Mitogenesis and Melanogenesis in Human Melanocytes. Biochem J. 314 ( Pt 1), 305-312.
94. Heanue, T. A., and Pachnis, V. (2007) Enteric Nervous System Development and Hirschsprung's Disease: Advances in Genetic and Stem Cell Studies. Nat Rev Neurosci. 8, 466-479.
95. Durbec, P. L., Larsson-Blomberg, L. B., Schuchardt, A., Costantini, F., and Pachnis, V. (1996) Common Origin and Developmental Dependence on c-Ret of Subsets of Enteric and Sympathetic Neuroblasts. Development. 122, 349-358.
96. Gianino, S., Grider, J. R., Cresswell, J., Enomoto, H., and Heuckeroth, R. O. (2003) GDNF Availability Determines Enteric Neuron Number by Controlling Precursor Proliferation. Development. 130, 2187-2198.
97. Natarajan, D., Marcos-Gutierrez, C., Pachnis, V., and de Graaff, E. (2002) Requirement of Signalling by Receptor Tyrosine Kinase RET for the Directed Migration of Enteric Nervous System Progenitor Cells during Mammalian Embryogenesis. Development. 129, 5151-5160.
98. Carrasquillo, M. M., McCallion, A. S., Puffenberger, E. G., Kashuk, C. S., Nouri, N., and Chakravarti, A. (2002) Genome-Wide Association Study and Mouse Model Identify Interaction between RET and EDNRB Pathways in Hirschsprung Disease. Nat Genet. 32, 237-244.
99. McCallion, A. S., Stames, E., Conlon, R. A., and Chakravarti, A. (2003) Phenotype Variation in Two-Locus Mouse Models of Hirschsprung Disease: Tissue-Specific Interaction between Ret and Ednrb. Proc Natl Acad Sci U S A. 100, 1826-1831.
100. Sumner, M. J., Cannon, T. R., Mundin, J. W., White, D. G., and Watts, I. S. (1992) Endothelin ETA and ETB Receptors Mediate Vascular Smooth Muscle Contraction. Br J Pharmacol. 107, 858-860.
101. Chen, Q. W., Edvinsson, L., and Xu, C. B. (2009) Role of ERK/MAPK in Endothelin Receptor Signaling in Human Aortic Smooth Muscle Cells. BMC Cell Biol. 10, 52-2121-10-52.
102. Cattaruzza, M., Dimigen, C., Ehrenreich, H., and Hecker, M. (2000) Stretch-Induced Endothelin B Receptor-Mediated Apoptosis in Vascular Smooth Muscle Cells. FASEB J. 14, 991-998.
103. Murakoshi, N., Miyauchi, T., Kakinuma, Y., Ohuchi, T., Goto, K., Yanagisawa, M., and Yamaguchi, I. (2002) Vascular Endothelin-B Receptor System in Vivo Plays a Favorable Inhibitory Role in Vascular Remodeling After Injury Revealed by Endothelin-B Receptor-Knockout Mice. Circulation. 106, 1991-1998.
104. Bremnes, T., Paasche, J. D., Mehlum, A., Sandberg, C., Bremnes, B., and Attramadal, H. (2000) Regulation and Intracellular Trafficking Pathways of the Endothelin Receptors. J Biol Chem. 275, 17596-17604.
105. Dupuis, J., Goresky, C. A., and Fournier, A. (1996) Pulmonary Clearance of Circulating Endothelin-1 in Dogs in Vivo: Exclusive Role of ETB Receptors. J Appl Physiol. 81, 1510-1515.
106. Fukuroda, T., Fujikawa, T., Ozaki, S., Ishikawa, K., Yano, M., and Nishikibe, M. (1994) Clearance of Circulating Endothelin-1 by ETB Receptors in Rats. Biochem Biophys Res Commun. 199, 1461-1465.
107. Sanchez, R., MacKenzie, A., Farhat, N., Nguyen, T. D., Stewart, D. J., Mercier, I., Calderone, A., and Thorin, E. (2002) Endothelin B Receptor-Mediated Regulation of Endothelin-1 Content and Release in Cultured Porcine Aorta Endothelial Cell. J Cardiovasc Pharmacol. 39, 652-659.
108. Tykocki, N. R., Gariepy, C. E., and Watts, S. W. (2009) Endothelin ET(B) Receptors in Arteries and Veins: Multiple Actions in the Vein. J Pharmacol Exp Ther. 329, 875-881.
109. Takayanagi, R., Kitazumi, K., Takasaki, C., Ohnaka, K., Aimoto, S., Tasaka, K., Ohashi, M., and Nawata, H. (1991) Presence of Non-Selective Type of Endothelin Receptor on Vascular Endothelium and its Linkage to Vasodilation. FEBS Lett. 282, 103-106.
110. Namiki, A., Hirata, Y., Ishikawa, M., Moroi, M., Aikawa, J., and Machii, K. (1992) Endothelin-1- and Endothelin-3-Induced Vasorelaxation Via Common Generation of Endothelium-Derived Nitric Oxide. Life Sci. 50, 677-682.
111. Liu, S., Premont, R. T., Kontos, C. D., Huang, J., and Rockey, D. C. (2003) Endothelin-1 Activates Endothelial Cell Nitric-Oxide Synthase Via Heterotrimeric G-Protein Betagamma Subunit Signaling to Protein Jinase B/Akt. J Biol Chem. 278, 49929-49935.
112. Haynes, W. G., and Webb, D. J. (1998) Endothelin as a Regulator of Cardiovascular Function in Health and Disease. J Hypertens. 16, 1081-1098.
113. Tsukahara, H., Ende, H., Magazine, H. I., Bahou, W. F., and Goligorsky, M. S. (1994) Molecular and Functional Characterization of the Non-Isopeptide-Selective ETB Receptor in Endothelial Cells. Receptor Coupling to Nitric Oxide Synthase. J Biol Chem. 269, 21778-21785.
114. Bagnall, A. J., Kelland, N. F., Gulliver-Sloan, F., Davenport, A. P., Gray, G. A., Yanagisawa, M., Webb, D. J., and Kotelevtsev, Y. V. (2006) Deletion of Endothelial Cell Endothelin B Receptors does Not Affect Blood Pressure Or Sensitivity to Salt. Hypertension. 48, 286-293.
115. Kohan, D. E., Padilla, E., and Hughes, A. K. (1993) Endothelin B Receptor Mediates ET-1 Effects on cAMP and PGE2 Accumulation in Rat IMCD. Am J Physiol. 265, F670-6.
116. Tomita, K., Nonoguchi, H., and Marumo, F. (1990) Effects of Endothelin on Peptide-Dependent Cyclic Adenosine Monophosphate Accumulation Along the Nephron Segments of the Rat. J Clin Invest. 85, 2014-2018.
117. Edwards, R. M., Stack, E. J., Pullen, M., and Nambi, P. (1993) Endothelin Inhibits Vasopressin Action in Rat Inner Medullary Collecting Duct Via the ETB Receptor. J Pharmacol Exp Ther. 267, 1028-1033.
118. Oishi, R., Nonoguchi, H., Tomita, K., and Marumo, F. (1991) Endothelin-1 Inhibits AVP-Stimulated Osmotic Water Permeability in Rat Inner Medullary Collecting Duct. Am J Physiol. 261, F951-6.
119. Nadler, S. P., Zimpelmann, J. A., and Hebert, R. L. (1992) Endothelin Inhibits Vasopressin-Stimulated Water Permeability in Rat Terminal Inner Medullary Collecting Duct. J Clin Invest. 90, 1458-1466.
120. Ahn, D., Ge, Y., Stricklett, P. K., Gill, P., Taylor, D., Hughes, A. K., Yanagisawa, M., Miller, L., Nelson, R. D., and Kohan, D. E. (2004) Collecting Duct-Specific Knockout of Endothelin-1 Causes Hypertension and Sodium Retention. J Clin Invest. 114, 504-511.
121. Gariepy, C. E., Ohuchi, T., Williams, S. C., Richardson, J. A., and Yanagisawa, M. (2000) Salt-Sensitive Hypertension in Endothelin-B Receptor-Deficient Rats. J Clin Invest. 105, 925-933.
122. Hoffman, A., Abassi, Z. A., Brodsky, S., Ramadan, R., and Winaver, J. (2000) Mechanisms of Big Endothelin-1-Induced Diuresis and Natriuresis : Role of ET(B) Receptors. Hypertension. 35, 732-739.
123. Vassileva, I., Mountain, C., and Pollock, D. M. (2003) Functional Role of ETB Receptors in the Renal Medulla. Hypertension. 41, 1359-1363.
124. Griswold, D. E., Douglas, S. A., Martin, L. D., Davis, T. G., Davis, L., Ao, Z., Luttmann, M. A., Pullen, M., Nambi, P., Hay, D. W., and Ohlstein, E. H. (1999) Endothelin B Receptor Modulates Inflammatory Pain and Cutaneous Inflammation. Mol Pharmacol. 56, 807-812.
125. Verheij, J. B., Kunze, J., Osinga, J., van Essen, A. J., and Hofstra, R. M. (2002) ABCD Syndrome is Caused by a Homozygous Mutation in the EDNRB Gene. Am J Med Genet. 108, 223-225.
126. Puffenberger, E. G., Hosoda, K., Washington, S. S., Nakao, K., deWit, D., Yanagisawa, M., and Chakravart, A. (1994) A Missense Mutation of the Endothelin-B Receptor Gene in Multigenic Hirschsprung's Disease. Cell. 79, 1257-1266.
127. Kusafuka, T., Wang, Y., and Puri, P. (1996) Novel Mutations of the Endothelin-B Receptor Gene in Isolated Patients with Hirschsprung's Disease. Hum Mol Genet. 5, 347-349.
128. Matsushima, Y., Shinkai, Y., Kobayashi, Y., Sakamoto, M., Kunieda, T., and Tachibana, M. (2002) A Mouse Model of Waardenburg Syndrome Type 4 with a New Spontaneous Mutation of the Endothelin-B Receptor Gene. Mamm Genome. 13, 30-35.
129. Demunter, A., De Wolf-Peeters, C., Degreef, H., Stas, M., and van den Oord, J. J. (2001) Expression of the Endothelin-B Receptor in Pigment Cell Lesions of the Skin. Evidence for its Role as Tumor Progression Marker in Malignant Melanoma. Virchows Arch. 438, 485-491.
130. Soufir, N., Meziani, R., Lacapere, J. J., Bertrand, G., Fumeron, F., Bourillon, A., Gerard, B., Descamps, V., Crickx, B., Ollivaud, L., Archimbaud, A., Lebbe, C., Basset-Seguin, N., Saiag, P., Grandchamp, B., and Investigators of the Melan-Cohort. (2005) Association between Endothelin Receptor B Nonsynonymous Variants and Melanoma Risk. J Natl Cancer Inst. 97, 1297-1301.
131. Dunn, L. C., and Charles, D. R. (1937) Studies on Spotting Patterns I. Analysis of Quantitative Variations in the Pied Spotting of the House Mouse. Genetics. 22, 14-42.
132. Gruneberg, H. (1952) The Genetics of the Mouse. Martinus Nijhoff, The Hague.
133. Lane, P. W. (1966) Association of Megacolon with Two Recessive Spotting Genes in the Mouse. J Hered. 57, 29-31.
135. Nishida, M., Ieshima, M., Konishi, F., Yamashita, J., Takaoka, M., and Matsumura, Y. (2002) Role of Endothelin B Receptor in the Pathogenesis of Ischemic Acute Renal Failure. J Cardiovasc Pharmacol. 40, 586-593.
|Science Writers||Anne Murray|
|Authors||Tiana Purrington and Bruce Beutler|
|List [record 1 of 1]|